Countering the Pandemic Threat Through Global Coordination on Vaccines

The COVID-19 pandemic has laid bare the fragility of the global system of preparedness and response to pandemics and the fragmentation of our research and development ecosystem. The pandemic has provided a disruptive moment to advance new norms and frameworks for influenza. It also has demonstrated how innovative global public-private partnerships and coordination mechanisms can lead to rapid successes in viral vaccine research, manufacturing, and risk pooling. Countering the Pandemic Threat Through Global Coordination on Vaccines identifies ways to strengthen pandemic and seasonal influenza global coordination, partnerships, and financing. This report presents seven overarching recommendations for how the urgent influenza threat should be conceptualized and prioritized within the global pandemic preparedness and response agenda in the future.Table of ContentsFront MatterSummary1 Introduction: The Imperative for Global Investment in Influenza Vaccines2 The Existing Global Governance Landscape for Influenza Vaccines3 Pathogen Sharing for Influenza Vaccine Production4 Technology and Manufacturing Partnerships5 Influenza Vaccine Access and Financing6 Recommendations and the Path ForwardAppendix A: Committee and Staff BiographiesAppendix B: Committee Meeting Agendas